$0.6552
-0.007-1.06%
At close: Nov 11, 4:00 PM EST
$0.7300
0.067810.24%
Pre-Market: 7:16 AM EST
Milestone Pharmaceuticals Inc
MISTNASDAQ
Milestone Pharmaceuticals fell 65.5% from $1.90 to $0.66, behind the S&P 500's +12.7%. Its worst day was Mar 20 (−20.0%), and its low came Oct 26 at $0.64.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Milestone Pharmaceuticals shares rose 16.0%, while the S&P 500 fell 0.9%.
+16.0% · S&P 500 −0.9%
Milestone Pharmaceuticals closed at its highest level of the year, 55.3% above where the year started.
Story events cover the past 12 months · Times ET
+10.5% · S&P 500 +0.2%
EPS of $-0.16 beat the $-0.18 estimate on $1.5M revenue (est. $1.2M).
−20.0%, the year's worst day · S&P 500 −1.4%
Milestone Pharmaceuticals shares rose 17.8%, while the S&P 500 rose 2.9%.
+17.8%, the year's best day · S&P 500 +2.9%
Milestone Pharmaceuticals shares rose 12.9%, while the S&P 500 rose 0.6%.
+12.9% · S&P 500 +0.6%
EPS of $-0.20 missed the $0.14 estimate on $238,000.00 revenue (est. $45.1M).
−9.5% · S&P 500 +0.6%
EPS of $-0.21 missed the $-0.19 estimate on $559,000.00 revenue (est. $813,336.00).
−11.4% · S&P 500 +0.3%
Milestone Pharmaceuticals closed at its lowest level of the year, 66.1% below where the year started.
−0.6% · S&P 500 +0.7%
Where it ended: a close of $0.66 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $-0.21, revenue est. $1.0M).
Nothing in the past 12 months.
All MIST dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MIST and SPY from Benzinga historical bars. Not investment advice.
